Cargando…
The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
Although cancers arise from genetic mutations enabling cells to proliferate uncontrollably, they cannot thrive without failure of the anticancer immunity due in a large part to the tumor environment's influence on effector and regulatory T cells. The field of immune checkpoint inhibitor (ICI) t...
Autores principales: | González-Navajas, Jose M., Fan, Dengxia Denise, Yang, Shuang, Yang, Fengyuan Mandy, Lozano-Ruiz, Beatriz, Shen, Liya, Lee, Jongdae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952426/ https://www.ncbi.nlm.nih.gov/pubmed/33717139 http://dx.doi.org/10.3389/fimmu.2021.625783 |
Ejemplares similares
-
The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy
por: Lee, Jongdae, et al.
Publicado: (2021) -
DMGV Is a Rheostat of T Cell Survival and a Potential Therapeutic for Inflammatory Diseases and Cancers
por: Yang, Fengyuan Mandy, et al.
Publicado: (2022) -
YAP9/A20 complex suppresses proinflammatory responses and provides novel anti-inflammatory therapeutic potentials
por: Yang, Fengyuan Mandy, et al.
Publicado: (2022) -
Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune Responses
por: Christensen, Lanette M., et al.
Publicado: (2022) -
ICOS(+) Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2020)